Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Other Non-Current Assets (2021 - 2026)

Invivyd's (IVVD) quarterly Other Non-Current Assets came in at $1.2 million in Q2 2026, up 7740.0% on a YoY basis from $15000.0 in Q2 2025, and up 969.09% quarter-over-quarter from $110000.0 in Q4 2025.

Analysis

Invivyd (IVVD) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Other Non-Current Assets for 6 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Assets rose 7740.0% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (up 7740.0% YoY), and the FY2025 full-year result was $110000.0, up 223.53% from the prior year.
  • Other Non-Current Assets grew to $1.2 million in Q2 2026 per IVVD's latest filing, from $110000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.5 million in Q3 2024 and bottomed at $6000.0 in Q3 2025.
  • Historically, Other Non-Current Assets has averaged $844823.5 across 5 years, with a median of $236000.0 in 2022.
  • The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets tumbled 99.92% in 2025, then surged 7740.0% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $191000.0 in 2022, then fell by 8.38% to $175000.0 in 2023, then tumbled by 80.57% to $34000.0 in 2024, then soared by 223.53% to $110000.0 in 2025, then soared by 969.09% to $1.2 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.2 million, $110000.0, and $6000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 124.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 65.13 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 831.80 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 104.44 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Mn
Dec 31, 2025 110,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 24,000.00
Dec 31, 2024 34,000.00
Sep 30, 2024 7.45 Mn
Jun 30, 2024 1.78 Mn
Mar 31, 2024 1.86 Mn
Dec 31, 2023 175,000.00
Sep 30, 2023 187,000.00
Jun 30, 2023 291,000.00
Mar 31, 2023 291,000.00
Dec 31, 2022 191,000.00
Sep 30, 2022 236,000.00
Jun 30, 2022 299,000.00
Mar 31, 2022 237,000.00
Dec 31, 2021 3.30 Mn
Sep 30, 2021 6.12 Mn